Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide in Psoriasis with Metabolic Comorbidities
NCT07401992Phase 4Recruiting
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Jan 2026
- Primary completion
- Feb 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide buccal patch (BUCCAL-PEP) in psoriasis, sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Started Jan 2026; status: recruiting.
02
Drugs
semaglutide buccal patch (BUCCAL-PEP)
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT07401992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07401992.